Column Group III-A, LP's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Feb 10, 2023
- Accession no.
- 0000899243-23-004584
- Filed
- Feb 10, 2023, 4:32 PM ET
- Trade date
- Feb 8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $3.90M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Column Group III-A, LPCIK 0001668085 | 10% Owner |
| Column Group III, LPCIK 0001668159 | 10% Owner |
| Column Group III GP, LPCIK 0001790965 | 10% Owner |
| Column Group Opportunity III, LPCIK 0001931825 | 10% Owner |
| TCG Opportunity III GP, LLCCIK 0001932445 | 10% Owner |
| Column Group Opportunity III GP, LPCIK 0001932874 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Common Stock | PPurchaseAcquired | +1,500,000 | $2.60 | +$3,900,000 | 11,370,274 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.